Blue Sail Medical: Inventory Below Current Price Supports Production Through End of June, Ensuring Q2 Excess Profit
April 30 report, Blue Sail Medical stated in response to inquiries from investors that the current raw material inventory below the current price can support production until the end of June, ensuring extra profits in the second quarter. The company's core strategic partners include Qixiang Tengda, a leading enterprise with a complete integrated industry chain from butadiene to finished nitrile latex (relevant cooperation matters have been disclosed on designated information disclosure media). Additionally, there are nitrile latex production capacities from industrial investors as emergency reserves, and affiliated party Langhui Petrochemical ensures the supply of raw materials for PVC gloves. The supply of the two core glove products is competitive in both quantity and price.
【Copyright and Disclaimer】The above information is collected and organized by PlastMatch. The copyright belongs to the original author. This article is reprinted for the purpose of providing more information, and it does not imply that PlastMatch endorses the views expressed in the article or guarantees its accuracy. If there are any errors in the source attribution or if your legitimate rights have been infringed, please contact us, and we will promptly correct or remove the content. If other media, websites, or individuals use the aforementioned content, they must clearly indicate the original source and origin of the work and assume legal responsibility on their own.
Most Popular
-
Layoffs, Divestments, Plant Closures While Pouring Billions: BASF Undergoes Major Transformation!
-
Ascend Adipic Acid Hit By Force Majeure, Market Expects Supply Resumption In Mid-September
-
Raw Material Supply Shortage! INEOS Phenol Declares Force Majeure on Phenol and Acetone Businesses
-
South Korea initiates anti-dumping investigation against Chinese PVC suspension resin! The target is Tianjin Bohua and Wanhua Chemical. How to break through?
-
Sixth national procurement set to be implemented: A “Reshuffling” Moment for the $10-Billion Medical Device Market
